Achromobacter xylosoxidans/denitrificans Bacteremia in a Patient With Good’s Syndrome

Choudhury, Saiara; Papineni, Sudhakar; Ramachandruni, Srikanth; Molina, J.I.; Surani, Salim

doi:10.7759/cureus.13827

Cited by 5 publications

(3 citation statements)

References 14 publications

(28 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These microorganisms are usually identified among people with weakened immune systems and patients with cystic fibrosis. Recently, these microorganisms have been noted as etiological agents that can cause pneumonia [44,45]. Importantly, only Burkholderia cepacia complex was found in the respiratory tract of patients with COVID-19 [46,47].…”

Section: Discussionmentioning

confidence: 99%

Contamination of Hospital Surfaces with Bacterial Pathogens under the Current COVID-19 Outbreak

Pochtovyi

Vasina

Kustova

et al. 2021

IJERPH

View full text Add to dashboard Cite

The SARS-CoV-2 pandemic remains a global health issue for several reasons, such as the low vaccination rates and a lack of developed herd immunity to the evolution of SARS-CoV-2, as well as its potential inclination to elude neutralizing antibodies. It should be noted that the severity of the COVID-19 disease is significantly affected by the presence of co-infections. Comorbid conditions are caused not only by pathogenic and opportunistic microorganisms but also by some representatives of the environmental microbiome. The presence of patients with moderate and severe forms of the disease in hospitals indicates the need for epidemiological monitoring of (1) bacterial pathogens circulating in hospitals, especially the ESKAPE group pathogens, and (2) the microbiome of various surfaces in hospitals. In our study, we used combined methods based on PCR and NGS sequencing, which are widely used for epidemiological monitoring. Through this approach, we identified the DNA of pathogenic bacteria (Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, CoNS, and Achromobacter spp.) on various surfaces. We also estimated the microbiome diversity of surfaces and identified the potential reservoirs of infections using 16S rRNA profiling. Although we did not assess the viability of identified microorganisms, our results indicate the possible risks of insufficient regular disinfection of surfaces, regardless of department, at the Infectious Diseases Hospital. Controlling the transmission of nosocomial diseases is critical to the successful treatment of COVID-19 patients, the rational use of antimicrobial drugs, and timely decontamination measures.

show abstract

Section: Discussionmentioning

confidence: 99%

Contamination of Hospital Surfaces with Bacterial Pathogens under the Current COVID-19 Outbreak

Pochtovyi

Vasina

Kustova

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…In addition to the common in ammatory diseases mentioned above, patients with GS are also prone to bacteremia, sepsis, meningitis, and hepatitis. Cytomegalovirus [63] COVID-19 [64][65][66][67] Pneumocystis jiroveci [68][69][70][71] Pseudomonas aeruginosa [18,44,72] Haemophilus in uenzae [73] Bordetella bronchiseptica [71] Achromobacter Xylosoxidans [74] 17.3% Enteritis Cytomegalovirus [23,57,75,76] Campylobacter [77] Giardia lamblia [78,79] 6.7%…”

Section: Infectious Diseases In Gs Patientsmentioning

confidence: 99%

“…Candida [18,23,30,62,89] 4.8% Bacteremia Staphylococcus [90] Escherichia coli [61] Alcaligenes sp. [91] Achromobacter Xylosoxidans [74] 3.8% Septicemia Campylobacter [23,54,92] 2.9% clinical features pathogen percentage…”

Section: Oral Candidiasismentioning

confidence: 99%

Good syndrome combined with myelodysplastic syndrome and multiple microbial pulmonary infections: A case report and literature review

Ye,

Wang,

Bao

et al. 2023

Preprint

View full text Add to dashboard Cite

Introduction Good syndrome (GS) is a rare acquired immunodeficiency disease characterized by thymoma and hypogammaglobulinemia that predisposes to the risk of recurrent infections with multiple pathogens. Case representation We describe the case of a 37-year-old male with GS who had a history of thymoma resection combined with myelodysplastic syndrome and was hospitalized multiple times for infections. The patient was admitted to our hospital with reoccurring fever, empirical antimicrobial therapy was ineffective, and Streptococcus pneumoniae, cytomegalovirus, cytomegalovirus, fine cyclic virus, Candida albicans, and Pneumocystis japonicus infections were identified by high-throughput sequencing technology (NGS) testing of alveolar lavage fluid, and the patient's symptoms resolved and immunity was improved with targeted anti-infective therapy. Conclusion When patients with thymoma have recurrent abnormal infections, immunologic testing should be performed to clarify whether GS is present, and anti-infective therapy should be aggressively administered.

show abstract

Good syndrome combined with multiple microbial pulmonary infections: case report and review of the literature

Ye,

Wang,

Bao

et al. 2024

Immunol Res

View full text Add to dashboard Cite

Achromobacter xylosoxidans/denitrificans Bacteremia in a Patient With Good’s Syndrome

Cited by 5 publications

References 14 publications

Contamination of Hospital Surfaces with Bacterial Pathogens under the Current COVID-19 Outbreak

Contamination of Hospital Surfaces with Bacterial Pathogens under the Current COVID-19 Outbreak

Good syndrome combined with myelodysplastic syndrome and multiple microbial pulmonary infections: A case report and literature review

Good syndrome combined with multiple microbial pulmonary infections: case report and review of the literature

Contact Info

Product

Resources

About